Carolin Wanzenried

Graduate Research Associate at Ridgeline Therapeutics - Basel, N/A, ch

Carolin Wanzenried's Contact Details
HQ
N/A
Location
Basel,Basel-Stadt,Switzerland
Company
Ridgeline Therapeutics
Carolin Wanzenried's Company Details
Ridgeline Therapeutics logo, Ridgeline Therapeutics contact details

Ridgeline Therapeutics

Basel, N/A, ch • 20 - 49 Employees
BioTech/Drugs

Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >70 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.

Biotechnology
Details about Ridgeline Therapeutics
Frequently Asked Questions about Carolin Wanzenried
Carolin Wanzenried currently works for Ridgeline Discovery.
Carolin Wanzenried's role at Ridgeline Discovery is Graduate Research Associate.
Carolin Wanzenried's email address is ***@ridgelinediscovery.com. To view Carolin Wanzenried's full email address, please signup to ConnectPlex.
Carolin Wanzenried works in the Research industry.
Carolin Wanzenried's colleagues at Ridgeline Therapeutics are Isabel Goeller, Frederic Delobel, Amelie Wiederkehr, Oliver Horlacher, Thomas Ryckmans, Eve Jakob, Alexander Flohr and others.
Carolin Wanzenried's phone number is N/A
See more information about Carolin Wanzenried